Consort Medical Seeks Acquisitions in Drug Handling, Diagnostics

Consort Medical Plc, the U.K. medical device company developing a new nicotine inhaling product with British American Tobacco Plc, is seeking to reduce its reliance on selling inhalers by investing in drug handling or diagnostic companies, said Chief Executive Officer Jonathan Glenn.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.